Multiple Myeloma Clinical Trials

A listing of Multiple Myeloma medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

Alabama

UPDATED

Birmingham Alabama 35294

A clinical trial to evaluate treatments using Lenalidomide, Bortezomib, Dexamethasone and Daratumumab for patients with Multiple Myeloma

UPDATED

Mobile Alabama 36608

Patients are needed to participate in a clinical research study evaluating Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone for the treatment of Multiple Myeloma

Arizona

UPDATED

Phoenix Arizona 85016

Patients are needed to participate in a clinical research study evaluating Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone for the treatment of Multiple Myeloma

UPDATED

Scottsdale Arizona 85054

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

Scottsdale Arizona 85054

A Phase 3 clinical study for patients with Plasma Cell Myeloma

UPDATED

Tucson Arizona 85711

Patients are needed to participate in a clinical research study evaluating Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone for the treatment of Multiple Myeloma

UPDATED

Tucson Arizona 85704

Patients are needed to participate in a clinical research study of Ixazomib, Lenalidomide and Dexamethasone to evaluate Multiple Myeloma

Arkansas

UPDATED

Fayetteville Arkansas 72703

A Phase 2 clinical study for patients with Multiple Myeloma (Panobinostat/Bortezomib/Dexamethasone)

UPDATED

Fayetteville Arkansas 72703

Patients are needed to participate in a clinical research study evaluating Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone for the treatment of Multiple Myeloma

UPDATED

Little Rock Arkansas 72205

A clinical trial seeking patients for a research study for the treatment of Multiple Myeloma

UPDATED

Little Rock Arkansas 72205

A Phase 3 clinical study for patients with Multiple Myeloma

California

UPDATED

Duarte California 91010

A clinical trial seeking patients for a research study for the treatment of Smoldering Multiple Myeloma

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using Lenalidomide, Bortezomib, Dexamethasone and Daratumumab for patients with Multiple Myeloma

UPDATED

Duarte California 91010

A clinical trial to evaluate treatments using RO6870810 and daratumumab for patients with Multiple Myeloma

UPDATED

Greenbrae California 94904

Patients are needed to participate in a clinical research study evaluating Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone for the treatment of Multiple Myeloma

UPDATED

La Jolla California 92093

A clinical trial to evaluate treatments using Lenalidomide, Bortezomib, Dexamethasone and Daratumumab for patients with Multiple Myeloma

View More ▼

UPDATED

Los Angeles California 90095

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

UPDATED

Los Angeles California 90017

A Phase 2 clinical study for patients with Multiple Myeloma (Panobinostat/Bortezomib/Dexamethasone)

UPDATED

San Francisco California 94117

A clinical trial seeking patients for a research study for the treatment of Haematological Malignancy, Multile Pyeolma (SAR650984)

UPDATED

West Hollywood California 90069

Patients are needed to participate in a clinical research study evaluating Oprozomib formulation 1, Oprozomib formulation 2, Dexamethasone and Pomalidomide for the treatment of Relapsed or Refractory Multiple Myeloma

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial to evaluate treatments using Lenalidomide, Bortezomib, Dexamethasone and Daratumumab for patients with Multiple Myeloma

UPDATED

Colorado Springs Colorado 80218

Patients are needed to participate in a clinical research study of Ixazomib, Lenalidomide and Dexamethasone to evaluate Multiple Myeloma

UPDATED

Denver Colorado 80218

A clinical trial to evaluate treatments using MEDI7247 for patients with Acute Myeloid Leukemia, Multiple Myeloma or Diffuse Large B-cell Lymphoma

UPDATED

Denver Colorado 80218

Patients are needed to participate in a clinical research study evaluating Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone for the treatment of Multiple Myeloma

UPDATED

Fort Collins Colorado 80528

A Phase 2 clinical study for patients with Multiple Myeloma (Panobinostat/Bortezomib/Dexamethasone)

Florida

UPDATED

Gainesville Florida 32608

A Phase 2 clinical study for patients with Multiple Myeloma (Panobinostat/Bortezomib/Dexamethasone)

UPDATED

Orlando Florida 32804

A clinical trial to evaluate treatments using Lenalidomide, Bortezomib, Dexamethasone and Daratumumab for patients with Multiple Myeloma

UPDATED

Plantation Florida 33322

A Phase 3 clinical study for patients with Plasma Cell Myeloma

UPDATED

Tampa Florida 33612

Patients are needed to participate in a clinical research study evaluating Oprozomib formulation 1, Oprozomib formulation 2, Dexamethasone and Pomalidomide for the treatment of Relapsed or Refractory Multiple Myeloma

Georgia

UPDATED

Atlanta Georgia 30322

A clinical trial to evaluate treatments using Lenalidomide, Bortezomib, Dexamethasone and Daratumumab for patients with Multiple Myeloma

UPDATED

Atlanta Georgia 30322

A clinical trial to evaluate treatments using RO6870810 and daratumumab for patients with Multiple Myeloma

UPDATED

Atlanta Georgia 30322

A Phase 2 clinical study for patients with Multiple Myeloma (Panobinostat/Bortezomib/Dexamethasone)

UPDATED

Atlanta Georgia 30322

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study evaluating Oprozomib formulation 1, Oprozomib formulation 2, Dexamethasone and Pomalidomide for the treatment of Relapsed or Refractory Multiple Myeloma

View More ▼

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Carfilzomib, Pomalidomide and Dexamethasone to evaluate Multiple Myeloma

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study of Daratumumab Subcutaneous (SC) infusion, Recombinant Human Hyaluronidase [rHuPH20]) SC infusion and Daratumumab Intravenous (IV) infusion to evaluate Multiple Myeloma, Relapsed or Refractory

UPDATED

Atlanta Georgia 30322

Patients are needed to participate in a clinical research study to evaluate Multiple Myeloma

Illinois

UPDATED

Chicago Illinois 60637

A clinical trial to evaluate treatments using Lenalidomide, Bortezomib, Dexamethasone and Daratumumab for patients with Multiple Myeloma

UPDATED

Chicago Illinois 60637-6613

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Chicago Illinois 60637-6613

Patients are needed to participate in a clinical research study evaluating Oprozomib formulation 1, Oprozomib formulation 2, Dexamethasone and Pomalidomide for the treatment of Relapsed or Refractory Multiple Myeloma

UPDATED

Niles Illinois 60714

Patients are needed to participate in a clinical research study evaluating Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone for the treatment of Multiple Myeloma

UPDATED

Niles Illinois 60714

Patients are needed to participate in a clinical research study of Ixazomib, Lenalidomide and Dexamethasone to evaluate Multiple Myeloma

Indiana

UPDATED

Fort Wayne Indiana 46804

A Phase 3 clinical study for patients with Plasma Cell Myeloma

UPDATED

Fort Wayne Indiana 46845

A Phase 3 clinical study for patients with Relapsed or Refractory Multiple Myeloma

UPDATED

Indianapolis Indiana 46260

Patients are needed to participate in a clinical research study to evaluate Multiple Myeloma

Kentucky

UPDATED

Louisville Kentucky 40207

Patients are needed to participate in a clinical research study evaluating Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone for the treatment of Multiple Myeloma

Maryland

UPDATED

Baltimore Maryland 21201

A clinical trial to evaluate treatments using Lenalidomide, Bortezomib, Dexamethasone and Daratumumab for patients with Multiple Myeloma

UPDATED

Bethesda Maryland 20817

Patients are needed to participate in a clinical research study evaluating Oprozomib formulation 1, Oprozomib formulation 2, Dexamethasone and Pomalidomide for the treatment of Relapsed or Refractory Multiple Myeloma

UPDATED

Columbia Maryland 21044

Patients are needed to participate in a clinical research study evaluating Daratumumab, Cyclophosphamide, Bortezomib and Dexamethasone for the treatment of Multiple Myeloma

Massachusetts

UPDATED

Boston Massachusetts 02115

A clinical research study of Ixazomib, Lenalidomide and Dexamethasone for the treatment of Smoldering Multiple Myeloma